Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 4696 AL 4710

A case of very long-term appearing drug tolerance to intrathecal baclofen

Dones I, Broggi G.

J Neurosurg Sci. 2010 Jun;54(2):77-8.

[The use of sirdalud MR in patients with multiple sclerosis]

Batysheva TT, Popova NF, Petrov SV, Kamchatnov PR, Zaĭtsev KA, Boĭko AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Pt 1):57-60.

Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review

Olvey EL, Armstrong EP, Grizzle AJ.

Clin Ther. 2010 Dec;32(14):2282-303. doi: 10.1016/j.clinthera.2011.01.005.

HTRA1 Disorder

Onodera O, Nozaki H, Fukutake T.

2010 Apr 27 [updated 2019 Nov 7]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Spastic Paraplegia 3A

Hedera P.

2010 Sep 21 [updated 2020 Jun 18]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Pediatric-onset dystonia associated with bilateral striatal necrosis and G14459A mutation in a Korean family: a case report

Kim IS, Ki CS, Park KJ.

J Korean Med Sci. 2010 Jan;25(1):180-4. doi: 10.3346/jkms.2010.25.1.180. Epub 2009 Dec 26.

The relationship between unimanual capacity and bimanual performance in children with congenital hemiplegia

Sakzewski L, Ziviani J, Boyd R.

Dev Med Child Neurol. 2010 Sep;52(9):811-6. doi: 10.1111/j.1469-8749.2009.03588.x. Epub 2010 Jan 28.

Marked improvement in Segawa syndrome after L-dopa and selegiline treatment

Yosunkaya E, Karaca E, Basaran S, Seven M, Yüksel A.

Pediatr Neurol. 2010 May;42(5):348-50. doi: 10.1016/j.pediatrneurol.2010.01.008.

A child with progressive dystonia, dysarthria, and spasticity

Schrock LE, Ostrem JL.

Rev Neurol Dis. 2010;7(1):32-3; discussion 39-42.

Combined ablative neurosurgical procedures in a patient with mixed spastic and dystonic cerebral palsy

Sitthinamsuwan B, Chanvanitkulchai K, Nunta-Aree S, Kumthornthip W, Pisarnpong A, Ploypetch T.

Stereotact Funct Neurosurg. 2010;88(3):187-92. doi: 10.1159/000313872. Epub 2010 May 1.

Development of the Hypertonia Assessment Tool (HAT): a discriminative tool for hypertonia in children

Jethwa A, Mink J, Macarthur C, Knights S, Fehlings T, Fehlings D.

Dev Med Child Neurol. 2010 May;52(5):e83-7. doi: 10.1111/j.1469-8749.2009.03483.x.

An update on the neurologic applications of botulinum toxins

Evidente VG, Adler CH.

Curr Neurol Neurosci Rep. 2010 Sep;10(5):338-44. doi: 10.1007/s11910-010-0129-z.

International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction

Esquenazi A, Novak I, Sheean G, Singer BJ, Ward AB.

Eur J Neurol. 2010 Aug;17 Suppl 2:1-8. doi: 10.1111/j.1468-1331.2010.03125.x.

Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: international consensus statement

Rawicki B, Sheean G, Fung VS, Goldsmith S, Morgan C, Novak I; Cerebral Palsy Institute.

Eur J Neurol. 2010 Aug;17 Suppl 2:122-34. doi: 10.1111/j.1468-1331.2010.03132.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias